Establishment of Risk Indicators and Early Warning System in Infection Patients
NCT ID: NCT05099120
Last Updated: 2022-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
16000 participants
OBSERVATIONAL
2010-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Biomarker Prediction Model of Septic Risk in Infected Patients
NCT05095324
Early Recognition and Dynamic Risk Warning System of Multiple Organ Dysfunction Syndrome Caused by Sepsis
NCT04904289
Early Identification and Prognosis Prediction of Sepsis Through Multiomics
NCT05305469
Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.
NCT01687010
The Early Prediction of Sepsis in ICU
NCT05088850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Do not accept follow-up
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingwen Wang
Role: STUDY_DIRECTOR
The First Affiliated Hospital of Air Force Medical University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jingwen Wang
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.